EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -53.56
December 31, 2025 -831.58
June 30, 2025 -2636.78
December 31, 2024 -6968.48
June 30, 2024 -19897.65
December 31, 2023 -192217.3
June 30, 2023 -4.536M
December 31, 2022 -7.581M
June 30, 2022 -5.776M
December 31, 2021 -8.089M
June 30, 2021 -13.43M
December 31, 2020 -72.22M
Date Value
June 30, 2020 -90.22M
December 31, 2019 -56.23M
June 30, 2019 -104.05M
December 31, 2018 -478.75M
June 30, 2018 -669.81M
December 31, 2017 -641.17M
June 30, 2017 -997.46M
December 31, 2016 0.00
June 30, 2016 -983.37M
December 31, 2015 -859.11M
June 30, 2015 -430.27M
June 30, 2014 0.00

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
NuCana Plc -3.220
Mereo BioPharma Group Plc -0.1752
BioNTech SE -6.868
Silence Therapeutics Plc -0.4231
Autolus Therapeutics Plc -1.050